First Personal Financial Services Alnylam Pharmaceuticals, Inc. Transaction History

First Personal Financial Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$88.31 - $107.8 $28,789 - $35,142	-326 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$115.92 - $148.54 $8,925 - $11,437	77 Added 30.92%	326 $39,000
Q4 2017 Jan 25, 2018	BUY	$114.49 - $139.98 $3,434 - $4,199	30 Added 13.7%	249 $32,000
Q3 2017 Nov 01, 2017	BUY	$72.53 - $118.27 $15,884 - $25,901	219	219 $26,000

614

108M

2.33M

2.17M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.